These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12141885)

  • 1. On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.
    Inadomi JM
    Pharmacoeconomics; 2002; 20(9):565-76. PubMed ID: 12141885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Lamers CB
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Remák E; Brown RE; Yuen C; Robinson A
    Curr Med Res Opin; 2005 Oct; 21(10):1505-17. PubMed ID: 16238890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts.
    Toghanian S; Wahlqvist P; Johnson DA; Bolge SC; Liljas B
    Clin Drug Investig; 2010; 30(3):167-78. PubMed ID: 20155989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: management of mild and severe gastro-oesophageal reflux disease.
    Tytgat GN
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():52-6. PubMed ID: 12786613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.